No patients required percutaneous endoscopic gastrostomy or nasal enteral feeding.<h4>Conclusions</h4>In patients with diabetes and gastroparesis, GLP-1 RA therapy was associated with significantly fewer pulmonary and systemic infectious complications. This evidence concerns the gene GLP1R and diabetes mellitus.